{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:36:53Z","timestamp":1793417813048,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The most prevalent cutaneous T-cell lymphoma is mycosis fungoides (MF), managed in early stages with psoralen plus ultraviolet A (PUVA) or narrowband ultraviolet B (NB-UVB) phototherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the therapeutic effectiveness and side effect profiles of PUVA vs. NB-UVB in patients with early-stage MF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A systematic review was conducted, incorporating data from nine studies sourced from PubMed, Cochrane and Google Scholar. Eligible studies were those that simultaneously evaluated PUVA and NB-UVB, enrolling at least 10 adult participants per group with histologically confirmed early-stage (IA\u2013IIA) MF and reported treatment outcomes. Exclusions were advanced disease, paediatric patients, noncomparative or nonrelevant treatments, small sample sizes or lack of outcome data. No language restrictions were applied. Key outcomes included any response, complete response, partial response, treatment failure, relapse-free interval and adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 923 patients (age range 33\u201371 years; 52.5% men) were included: 556 treated with PUVA and 367 with NB-UVB. Any response was seen in 90.5% of those treated with PUVA vs. 88.3% of patients who received NB-UVB [odds ratio (OR) 1.18, 95% confidence interval (CI) 0.73\u20131.90; P = 0.50]. Complete response rates were 72% for those treated with PUVA and 61.8% for those treated with NB-UVB (OR 1.12, 95% CI 0.60\u20132.07; P = 0.73). Partial response was observed in 19.2% of patients who received PUVA and 28.0% of those who received NB-UVB (OR 0.87, 95% CI 0.45\u20131.69; P = 0.69). Treatment failure rates were lower with PUVA (9.7%) than with NB-UVB (12.6%) (OR 0.81, 95% CI 0.49\u20131.33; P = 0.41). Patients who received PUVA had a significantly longer median relapse-free interval (hazard ratio 1.94, 95% CI 1.07\u20133.51; P &amp;lt; 0.01). Adverse effects, including erythema, nausea, pruritus, burning, hyperpigmentation, pain, phototoxic reactions and polymorphic light eruption, showed no significant differences between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both PUVA and NB-UVB are effective, but PUVA may be preferred when sustained remission is the primary therapeutic goal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/skinhd\/vzag055","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:17:29Z","timestamp":1773404249000},"page":"406-414","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of narrowband ultraviolet B with psoralen plus ultraviolet A phototherapy for patients with early-stage mycosis fungoides: a systematic review and\u00a0meta-analysis"],"prefix":"10.1093","volume":"6","author":[{"given":"Serish","family":"Bano","sequence":"first","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari , Karachi ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F N U","family":"Sidra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari , Karachi ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F N U","family":"Venjhraj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari , Karachi ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutahira","family":"Asif","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari , Karachi ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aghna","family":"Iman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari , Karachi ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F N U","family":"Fatima","sequence":"additional","affiliation":[{"name":"Federal Medical College, SZABMU , Islamabad ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meva","family":"Ram","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari , Karachi ,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-1215","authenticated-orcid":false,"given":"Aymar","family":"Akilimaili","sequence":"additional","affiliation":[{"name":"Department of Research, Medical Research Circle (MedReC) , Goma ,","place":["Democratic Republic of the Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2026073105081452100_vzag055-B1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.critrevonc.2007.08.004","article-title":"Mycosis fungoides","volume":"65","author":"Zinzani","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026073105081452100_vzag055-B2","first-page":"491","article-title":"Diagnosis and management of mycosis fungoides","volume":"24","author":"Galper","year":"2010","journal-title":"Oncology"},{"key":"2026073105081452100_vzag055-B3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000458149","article-title":"Ultraviolet A1 phototherapy in the treatment of early mycosis fungoides","volume":"233","author":"Adl\u015fen","year":"2017","journal-title":"Dermatology"},{"key":"2026073105081452100_vzag055-B4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1523-1747.ep12265126","article-title":"Alteration of lymphocyte functions by 8-methoxypsoralen and long-wave ultraviolet radiation. I. Suppressive effects of PUV A on T-lymphocyte migration in vitro","volume":"84","author":"Uki Okamoto","year":"1985","journal-title":"J Invest Dermatol"},{"key":"2026073105081452100_vzag055-B5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2133.1999.02898.x","article-title":"The effects of ultraviolet radiation on the human immune system","volume":"140","author":"Duthie","year":"1999","journal-title":"Br J Dermatol"},{"key":"2026073105081452100_vzag055-B6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"2026073105081452100_vzag055-B7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jid.2023.08.029","article-title":"Psoralen plus UVA induces local IFN production and antitumor responses in cutaneous T-cell lymphoma","volume":"144","author":"Goel","year":"2024","journal-title":"J Invest Dermatol"},{"key":"2026073105081452100_vzag055-B8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.5021\/ad.2011.23.4.474","article-title":"Narrowband ultraviolet B phototherapy of early stage mycosis fungoides in Korean patients","volume":"23","author":"Jang","year":"2011","journal-title":"Ann Dermatol"},{"key":"2026073105081452100_vzag055-B9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.jidsp.5640185","article-title":"Mechanisms of ultraviolet (UV) B and UVA phototherapy","volume":"4","author":"Krutmann","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2026073105081452100_vzag055-B10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamadermatol.2018.5204","article-title":"Comparison of narrowband UV-B with psoralen-UV-A phototherapy for patients with early-stage mycosis fungoides: a systematic review and meta-analysis","volume":"155","author":"Phan","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2026073105081452100_vzag055-B11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026073105081452100_vzag055-B12","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026073105081452100_vzag055-B13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2026073105081452100_vzag055-B14","author":"National Cancer Institute"},{"key":"2026073105081452100_vzag055-B15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"2026073105081452100_vzag055-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"2026073105081452100_vzag055-B17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/phpp.12873","article-title":"Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: a single-center cross-sectional study","volume":"39","author":"Zengarini","year":"2023","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026073105081452100_vzag055-B18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/phpp.12611","article-title":"A retrospective, descriptive study of patients with mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years","volume":"37","author":"Pattamadilok","year":"2021","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026073105081452100_vzag055-B19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2340\/00015555-0283","article-title":"Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study","volume":"87","author":"Ahmad","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"2026073105081452100_vzag055-B20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.clml.2017.06.015","article-title":"Bath psoralen-ultraviolet A and narrowband ultraviolet B phototherapy as initial therapy for early-stage mycosis fungoides: a retrospective cohort of 267 cases at the University of Toronto","volume":"17","author":"Almohideb","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026073105081452100_vzag055-B21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1067\/mjd.2003.80","article-title":"Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study","volume":"48","author":"Diederen","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"2026073105081452100_vzag055-B22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0781.2005.00183.x","article-title":"Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study","volume":"21","author":"El-Mofty","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026073105081452100_vzag055-B23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/phpp.12383","article-title":"Phototherapy as a first-line treatment for early-stage mycosis fungoides: the results of a large retrospective analysis","volume":"34","author":"Nikolaou","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026073105081452100_vzag055-B24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1468-3083.2009.03500.x","article-title":"Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides","volume":"24","author":"Ponte","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105081452100_vzag055-B25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.15321\/GenelTipDer.2015313137","article-title":"Mikozis fungoides tedavisinde dbuvb ve puva: Retrospektif de\u011ferlendirme","volume":"25","author":"Unal","year":"2015","journal-title":"Genel T\u0131p Dergisi"},{"key":"2026073105081452100_vzag055-B26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2019.07.075","article-title":"Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: a surveillance, epidemiology, and end results analysis","volume":"83","author":"Goyal","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026073105081452100_vzag055-B27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2003.05698.x","article-title":"Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas","volume":"149","author":"Whittaker","year":"2003","journal-title":"Br J Dermatol"},{"key":"2026073105081452100_vzag055-B28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaad.2011.04.004","article-title":"The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study","volume":"66","author":"Stern","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2026073105081452100_vzag055-B29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1365-2133.1999.02928.x","article-title":"PUVA and cancer risk: the Swedish follow-up study","volume":"141","author":"Lindel\u00f6f","year":"1999","journal-title":"Br J Dermatol"},{"key":"2026073105081452100_vzag055-B30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0781.2004.00125.x","article-title":"Psoralen ultraviolet A therapy in 2004","volume":"20","author":"Morison","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2026073105081452100_vzag055-B31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","article-title":"Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Archier","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026073105081452100_vzag055-B32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2133.2004.06128.x","article-title":"An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report","volume":"151","author":"Ibbotson","year":"2004","journal-title":"Br J Dermatol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/4\/406\/68527900\/vzag055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/4\/406\/68527900\/vzag055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:08:21Z","timestamp":1785488901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/4\/406\/8708148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,15]]},"published-print":{"date-parts":[[2026,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzag055","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,6,15]]}}}